Effects of platelet-activating factor on intracellular Ca2+ concentration and contractility in isolated cardiomyocytes

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 5, 1998, Pages 758-763

  Pietsch, Peter ^a   Hunger, Thomas ^a   Braun, Marina ^a   Roediger, Andrea ^a   Baumann, Gert ^a   Felix, Stephan B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Contractility; Intracellular Ca2+; Isolated cardiomyocytes; Platelet activating factor; Rat

Indexed keywords

BEPAFANT; CALCIMYCIN; CALCIUM ION; DIGITONIN; DIMETHYL SULFOXIDE; FLUORESCENT DYE; MANGANESE CHLORIDE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; AZEPINES; CALCIUM; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; TRIAZOLES;

EID: 0031968386     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199805000-00015     Document Type: Article

References (25)

1. Chao W, Olson MS. Platelet-activating factor: receptors and signal transaction. Biochem J 1993;292:617-29.
2. McManus LM, Woodard DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications. Lab Invest 1993;69:639-49.
3. Feuerstein G, Rabinovici R, Leor J, Winkler JD, Vonhof S. Platelet activating factor and cardiac diseases: therapeutic potential for PAF inhibitors. J Lipid Med Cell Signal 1997;15:255-84.
4. Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet activating factor (PAF): a review of its effects, antagonists and possible future clinical implications (part I). Drugs 1991;42:9-29.
5. Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. PAF: a review of its effects, antagonists and possible future clinical implications (part II). Drugs 1991;42:174-204.
6. McManus LM, Hanahan DJ, Demopoulus CA, Pinckard RN. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet activating factor (PAF), in the rabbit. J Immunol 1980;124:2919-24.
7. Bessin P, Bonnet C, Apffel D, et al. Acute circulatory collapse caused by platelet activating factor (PAF-acether) as studied by intravital microscopy. Eur J Pharmacol 1983;86:403-13.
8. Benveniste J, Boullet C, Brink C, Labat C. The actions of PAF-acether (platelet activating factor) on guinea pig isolated heart preparations. Br J Pharmacol 1983;80:81-3.
9. 4. Br J Pharmacol 1986;88:595-605.
10. Felix SB, Baumann G, Ahmad Z, Hashemi T, Niemczyk M, Berdel WE. Effects of platelet-activating factor on myocardial contraction and myocardial relaxation of isolated perfused guinea pig hearts. J Cardiovasc Pharmacol 1990;16:750-6.
11. Massey CV, Kohout TA, Gaa ST, Lederer WJ, Rogers TB. Molecular and cellular actions of platelet-activating factor in rat heart cells. J Clin Invest 1991;88:2106-16.
12. Delbridge LM, Steward AG, Goulter CM, Morgan TO, Harris PJ. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility. J Mol Cell Cardiol 1994;26:185-93.
13. Thomas AP, Delaville F. The use of fluorescent indicators for measurements of cytosolic free calcium concentration in cell populations and single cells. In: McCormack JG, Cobbold PH, eds. Cellular calcium. New York: Oxford University Press, 1991:1-53.
14. Kao JPY, Harootunian AT, Tsien RY. Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem 1989;264:8179-84.
15. Williams DA. Quantitative calcium imaging with laser-scanning confocal microscopy. Cell Calcium 1990;11:589-97.
16. Williams DA, Delbridge LM, Cody SH, Harris PJ, Morgan TO. Spontaneous and propagated calcium release in isolated cardiac myocytes viewed by confocal microscopy. Am J Physiol 1992;262:C731-42.
17. Heuer HO, Casals-Stenzel J. Muacevic G, Weber K-H. Pharmacological activity of bepafant: a new and selective hetrazinepineoic antagonist of platelet activating factor. J Pharmacol Exp Ther 1990;255:962-8.
18. Alloatti G, Montrucchio G, Emanuelli G, Camussi G. Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. J Mol Cell Cardiol 1992;24:163-71.
19. Raschke P, Becker BF. Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia. Cardiovasc Res 1995;29:569-76.
20. Felix SB, Baumann G, Raschke P, Maus C, Berdel WE. Cardiovascular reactions and respiratory events during platelet activating factor-induced shock. Basic Res Cardiol 1990;85:217-26.
21. Church DJ, van der Bent V, Vallotton MB, Capponi AM, Lang U. Calcium influx in platelet activating factor induced atrial natriuretic peptide release. Am J Physiol 1994;266:E403-9.
22. Woodcock EA, Tanner JK, Fullerton M, Kuraja IJ. Different pathways of inositol phosphate metabolism in intact neonatal rat hearts and isolated cardiomyocytes. Biochem J 1992;281:683-8.
23. Bito H, Honda Z, Nakamura M, Shimizu T. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem 1994;221:211-8.
24. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, Hsueh W. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet activating factor and endogenous tumour necrosis factor. Biochem J 1997;322:603-8.
25. Casals-Stenzel J, Muacevic G, Weber KH. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther 1987;241:974-81.